Corpus Intelligence IC Memo — AURORA BHS OF ARIZONA 2026-04-26 09:37 UTC
IC Memo — AURORA BHS OF ARIZONA
Investment Committee Memorandum | AZ | 100 beds | Grade D | EBITDA uplift $2.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AURORA BHS OF ARIZONA

CCN 034024 | MARICOPA, AZ | 100 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

AURORA BHS OF ARIZONA is a 100-bed suburban community hospital in MARICOPA, AZ with $31.2M in net patient revenue and a -8.2% operating margin. The hospital serves a payer mix of 3.8% Medicare, 3.4% Medicaid, and 92.8% commercial.

Thesis: Turnaround. Our ML models identify $2.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.2% to -0.9% (+736bps).

Net Revenue HCRIS$31.2M
Current EBITDA COMPUTED$-2.6M
Operating Margin COMPUTED-8.2%
Occupancy HCRIS85.1%
Revenue / Bed COMPUTED$312K
Net-to-Gross HCRIS56.2%
Distress Probability ML43.0%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
54
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -8.2% places it below the state median. Among 54 size-comparable peers (50-200 beds), the median margin is 1.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-200), prioritizing same-state peers. 54 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AURORA BHS OF ARIZONA (Target)AZ100$31.2M-8.2%
BANNER GATEWAY MEDICAL CENTERAZ185$573.8M5.2%
MERCY GILBERT MEDICAL CENTERAZ197$381.9M6.3%
KINGMAN REGIONAL MEDICAL CENTEAZ196$373.6M-6.0%
HAVASU REGIONAL MEDICAL CENTERAZ144$256.1M16.9%
SUMMIT HEALTHCAREAZ89$254.1M-2.9%
MOUNTAIN VISTA MEDICAL CENTERAZ162$223.9M-1.0%
BANNER UNIVERSITY MED CENTER SAZ132$190.9M-16.3%
HONORHEALTH SCOTTSDALE THOMPSOAZ120$187.9M-1.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$656K+210bp18mo
Cost to Collect4.5%2.5%$625K+200bp12mo
Denial Rate Reduction12.0%6.5%$619K+198bp12mo
A/R Days Reduction5200.0%3800.0%$380K+122bp9mo
Clean Claim Rate88.0%96.0%$20K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$656K
Cost to Collect
$625K
Denial Rate Reduction
$619K
A/R Days Reduction
$380K
Clean Claim Rate
$20K
Total EBITDA Uplift$2.3M
Current EBITDA$-2.6M
+ RCM Uplift+$2.3M
Pro Forma EBITDA$-269K
Current Margin-8.2%
Pro Forma Margin-0.9%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.0M$6.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.0M$5.4M0.00x-100.0%
Bull Case9.0x11.0x$-3.6M$11.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.6M$11.7M0.00x-100.0%
Bear Case11.0x10.0x$-4.3M$-4.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.3M$-6.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 54 hospitals with 50-200 beds
  • Same-state prioritization (n=55)
  • Comp margins: P25=-10.6% / P50=1.9% / P75=10.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.